BRIANNE SHERGILL
@Exome Asset Management Llc
Latest period2024 - Q3ReportedManaged Assets$293.574MTotal holdings59
Assets growth rate161.38%Assets growth rate (2-Q avg)78.78%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Exome Asset Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 59 positions.
Assets under management
The assets under management (AUM) of Exome Asset Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 293.574M in assets, with a quarterly growth rate of 161.38% and a 2-quarter average growth rate of 78.78%. The portfolio is managed by BRIANNE SHERGILL, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
GPCRStructure Therapeutics Inc
| 3.6% | $10.548M 240,330 shares@ $43.9 avg price | New Position |
ALGNAlign Technology Inc
| 3.24% | $9.512M 37,400 shares@ $254.32 avg price | New Position |
GILDGilead Sciences Inc
| 2.86% | $8.384M 100,000 shares@ $83.84 avg price | New Position |
GERNGeron Corp
| 2.8% | $8.219M 1.81M shares@ $4.54 avg price | New Position |
BNTXBiontech Se
| 2.8% | $8.207M 69,104 shares@ $118.77 avg price | New Position |
BMYBristol-myers Squibb Co
| 2.75% | $8.071M 156,000 shares@ $51.74 avg price | New Position |
VRDNViridian Therapeutics Inc
| 2.71% | $7.935M 348,800 shares@ $22.75 avg price | New Position |
BPMCBlueprint Medicines Corp
| 2.32% | $6.79M 73,400 shares@ $92.5 avg price | New Position |
GKOSGlaukos Corp
| 2.3% | $6.737M 51,714 shares@ $130.29 avg price | New Position |
SWTXSpringworks Therapeutics Inc
| 2.2% | $6.453M 201,400 shares@ $32.04 avg price | New Position |